Yonsei University Health System Severance Hospital

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Active, not recruiting	Phase 2	2026-07-22		NCT05060016
A Study of Lorigerlimab in Participants With Advanced Solid Tumors	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, cervical clear cell adenocarcinoma, endometrium neoplasm, fallopian tube clear cell adenocarcinoma, female reproductive system disorder, female reproductive system neoplasm, neoplasm, ovarian clear cell adenocarcinoma, uterine disorder	Recruiting	Phase 2	2026-06-02		NCT06730347

Clinical trials